Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gustavo Samaja"'
Autor:
Esteban J. Estrada, José Luis Decima, Guillermo Bortman, Javier Roberti, Elida Beatriz Romero, Gustavo Samaja, Aldo Rodríguez Saavedra, Gerardo Martínez, Samuel Gutiérrez
Publikováno v:
Cell Transplantation, Vol 28 (2019)
The objective of this study was to compare standard treatment versus the combination of intrapancreatic autologous stem cell (ASC) infusion and hyperbaric oxygen treatment (HBOT) before and after ASC in the metabolic control of patients with type 2 d
Externí odkaz:
https://doaj.org/article/fbb4a734d6c944a585e19098e42e3326
Autor:
Elida Beatriz Romero, Guillermo Bortman, Gustavo Samaja, Esteban J. Estrada, Javier Roberti, Jose L. Decima, G. Martinez, Aldo Rodríguez Saavedra, Samuel Gutiérrez
Publikováno v:
Cell Transplantation
Cell Transplantation, Vol 28 (2019)
Cell Transplantation, Vol 28 (2019)
The objective of this study was to compare standard treatment versus the combination of intrapancreatic autologous stem cell (ASC) infusion and hyperbaric oxygen treatment (HBOT) before and after ASC in the metabolic control of patients with type 2 d
Publikováno v:
Revista Argentina de Cardioangiología Intervencionista. 5:0137-0139
Publikováno v:
Medicina (Buenos Aires), Vol 67, Iss 3, Pp 271-273 (2007)
La punción percutánea de la arteria radial para la realización de procedimientos por cateterismo ha ganado aceptación debido a una eficacia similar a la obtenida con el acceso femoral. En el presente trabajo evaluamos los resultados obtenidos con
Publikováno v:
Medicina. 67(3)
Repeated radial artery puncture for cardiac catheterization. The radial artery approach for percutaneous cardiac interventions has gained worldwide acceptance due to the similar results obtained by the femoral artery access. In this paper, we report
Autor:
Aldo Rodríguez Saavedra, Esteban J. Estrada, Eduardo A. Nicora, María Julia Esperanza, Jose L. Decima, Elida Beatriz Romero, Gustavo Samaja
Publikováno v:
Molecular Therapy. 23:S150
T2DM is a pandemic disease with a serious health complications, however stem cells therapy appear to be a new therapeutic option.This prospective, open labeled, randomized controlled clinical trial a phase I/II study, comparing the benefit of hyperba